Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions
Cancer Epidemiology, Biomarkers & Prevention, 07/11/2012
Kruzikas DT et al. – Results reveal high rates of use and high associated costs of diagnostic procedures and treatments related to disease attributed to human papillomavirus (HPV). The data presented may be useful in cost–effectiveness analyses and to guide decision makers evaluating how best to optimize prevention strategies.